MEGAN JOHNSON: Open Payments
NPI 1902051386 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,866 in 135 payments from 14 companies in 2025. Trend: 2023 $1,701 · 2024 $3,848 · 2025 $2,866
Food & beverage: $2,815Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $780 |
| Janssen Biotech, Inc. | 32 | $649 |
| Ardelyx, Inc. | 18 | $363 |
| GENZYME CORPORATION | 8 | $217 |
| PFIZER INC. | 15 | $202 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Janssen Scientific Affairs, LLC | 1 | $112 |
| Phathom Pharmaceuticals, Inc. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
Products named: TREMFYA, IBSRELA, SKYRIZI, DUPIXENT, RINVOQ, IQIRVO, XELJANZ, LINZESS.
Industry payments across LA — which companies pay providers there.
